From 2013 to 2023, the export of composite diagnostic or laboratory reagents from Belgium exhibited a declining trend, decreasing from 1.0964 Billion USD to 0.64692 Billion USD. The year-on-year decline rates varied, with notable drops in 2015 (-15.23%), 2018 (-16.51%), and a general declining CAGR oscillating between -2.11% and -9.53%. By 2023, the value stood at 0.64692 Billion USD, showing a consistent yet less steep decline compared to previous years. Over the last two years (2022-2023), the year-on-year variation slightly decreased, reflecting smaller percentage drops compared to the earlier years.

The forecast from 2024 to 2028 suggests a continuation of this declining trend, with an average annual decline rate (CAGR) of -1.49%, leading to an anticipated 7.23% decline over the next five years. This could result in the export value reaching 0.58883 Billion USD by 2028.

Future trends to watch for include:

Potential impacts of technological advancements in diagnostic and laboratory reagents.
Shifts in global demand and competition from other countries.
Regulatory changes affecting production and export.